Search results
Economist who predicted recession reveals signs economy is on downturn
Daily Mail· 6 days ago'Nvidia alone accounted for nearly one-third of the S&P 500's total return in the first half of this...
6 stocks that Fools have been buying!
Fool.co.uk via Yahoo Finance UK· 7 days agoOur Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks. The post 6 stocks that Fools have been...
Novo owner backs Swiss biotech Asceneuron in $100 million round
Reuters· 5 days agoSwiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including...
Reform isn't going anywhere
The New Statesman· 4 days agoA desire for stability and security above all else is what sent so many mortgage-owners and those of middling affluence into Labour’s arms at the 2024...
Roche shares jump after weight-loss pill shows promise in study
Irish Examiner· 4 days agoAn oral medicine is one of the as-yet-untapped areas in a weight-loss market that Goldman Sachs...
Acute Migraine Treatment Market is growing at an 8.7% CAGR and is expected to reach USD 8.6 Billion
PharmiWeb· 7 days agoThe global Acute Migraine Treatment Market is on the rise, driven by the increasing prevalence of migraine headaches. According to recent projections, the market is set to reach a value of USD ...
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market
Reuters· 6 days agoDemocratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout...
Nvidia shares are soaring! Could this AI stock be a better buy?
Fool.co.uk via Yahoo Finance UK· 2 days agoDemand for Nvidia shares continues to grow and grow. But might this cheaper AI stock be a superior...
Roche reports positive early results in obesity drug trial
Reuters· 4 days ago, opens new tab said on Wednesday its CT-996, a new drug being developed to treat obesity and type 2...
Ozempic may gift US a $3 trln benefit
Reuters· 4 days agoThe United States spends 17% of its gross domestic product on healthcare, about twice as much as the average OECD country, according to the Commonwealth...
